The Rationale for an Acute Heart Failure Syndromes Clinical Trials Network

Journal of Cardiac Failure

Volumn 15, Issue 6, 2009, Pages 467-474

  Collins, Sean P ^a   Levy, Phillip D ^b   Lindsell, Christopher J ^a   Pang, Peter S ^c   Storrow, Alan B ^d   Miller, Chadwick D ^e   Naftilan, Allen J ^d   Thohan, Vinay ^e   Abraham, William T ^f   Hiestand, Brian ^f   Filippatos, Gerasimos ^g   Diercks, Deborah B ^h   Hollander, Judd ⁱ   Nowak, Richard ^j   Peacock, W Frank ^k   Gheorghiade, Mihai ^c  

^a UNIVERSITY OF CINCINNATI   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e WAKE FOREST UNIVERSITY   (United States)

^f OHIO STATE UNIVERSITY   (United States)

^g EVANGELISMOS HOSPITAL   (Greece)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

^j HENRY FORD HOSPITAL   (United States)

^k LERNER RESEARCH INSTITUTE   (United States)

more..

Author keywords

Acute heart failure syndromes; cardiology; clinical trials network; emergency department

Indexed keywords

ACUTE HEART FAILURE; ARTICLE; CARDIAC PATIENT; CLINICAL EFFECTIVENESS; CLINICAL RESEARCH; EMERGENCY CARE; EMERGENCY WARD; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MEDICAL ETHICS; METHODOLOGY; MORTALITY; PATIENT IDENTIFICATION; PATIENT SELECTION; PRIORITY JOURNAL; RISK ASSESSMENT; STANDARDIZATION; TREATMENT OUTCOME;

EID: 67651037374     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2008.12.013     Document Type: Article

References (76)

1. J.B. O'Connell M. Bristow Economic impact of heart failure in the United States: a time for a different approach J Heart Lung Trans 13 1994 S107 S112
2. L.W. Stevenson E. Braunwald Recognition and management of patients with heart failure L. Goldman E. Braunwald Primary cardiology 1998 WB Saunders Philadelphia 310 329
3. American Heart Association Heart disease and stroke statistics—2005 update 2004 AHA Dallas, TX
4. M. Gheorghiade M.A. Konstam J.C. Burnett Jr. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials JAMA 297 2007 1332 1343
5. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial JAMA 287 2002 1531 1540
6. A. Mebazaa M.S. Nieminen M. Packer Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial JAMA 297 2007 1883 1891
7. L.D. Luca G.C. Fonarow A. Mebazaa Acute heart failure syndromes: clinical scenarios and pathophysiologic targets for therapy Acute Cardiac Care 12 2007 10 21
8. M. Gheorghiade W.T. Abraham N.M. Albert Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure JAMA 296 2006 2217 2226
9. J.G. Cleland K. Swedberg F. Follath The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis Eur Heart J 24 2003 442 463
10. K.F. Adams Jr. G.C. Fonarow C.L. Emerman Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE) Am Heart J 149 2005 209 216
11. M.S. Cuffe R.M. Califf K.F. Adams Jr. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial JAMA 287 2002 1541 1547
12. S.E. Reis R. Holubkov D. Edmundowicz Treatment of patients admitted to the hospital with congestive heart failure: specialty-related disparities in practice patterns and outcomes J Am Coll Cardiol 30 1997 733 738
13. C.W. Yancy Climbing the mountain of acute decompensated heart failure: the EVEREST Trials JAMA 297 2007 1374 1376
14. L. Graff J. Orledge M.J. Radford Y. Wang M. Petrillo R. Maag Correlation of the Agency for Health Care Policy and Research congestive heart failure admission guideline with mortality: peer review organization voluntary hospital association initiative to decrease events (PROVIDE) for congestive heart failure Ann Emerg Med 34 1999 429 437
15. C.A. Polanczyk L.E. Rohde E.A. Philbin T.G. Di Salvo A new casemix adjustment index for hospital mortality among patients with congestive heart failure Med Care 36 1998 1489 1499
16. W.R. Smith R.M. Poses D.K. McClish Prognostic judgments and triage decisions for patients with acute congestive heart failure Chest 121 2002 1610 1617
17. J.H. Han C. Zhou D.J. France The effect of emergency department expansion on emergency department overcrowding Acad Emerg Med 14 2007 338 343
18. A.H. Wu A. Harrison A.S. Maisel Reduced readmission rate for alternating diagnoses of heart failure and pulmonary disease after implementation of B-type natriuretic peptide testing Eur J Heart Fail 6 2004 309 312
19. Dolcourt B, Bilkovski R, Waiting for a bed: do prolonged ED waits translate to adverse outcomes. In: Society of Academic Emergency Medicine. Chicago; 2007. p. S84.
20. IOM Hospital-based emergency care: at the breaking point 2006 National Academies Press Washington, D.C p. 1–296
21. J.M. Pines J.E. Hollander Emergency department crowding is associated with poor care for patients with severe pain Ann Emerg Med 51 2008 1 5 discussion 6–7
22. A. Sacchetti E. Ramoska M.E. Moakes P. McDermott V. Moyer Effect of ED management on ICU use in acute pulmonary edema Am J Emerg Med 17 1999 571 574
23. M. Gheorghiade F. Zannad G. Sopko Acute heart failure syndromes: current state and framework for future research Circulation 112 2005 3958 3968
24. Pang PS, Tavares M, Collins SP, Peacock WF, Hamdy A, Cleland JGF, Gheorghiade M, for the URGENT Investigators. The early assessment of dyspnea in patients with acute heart failure syndromes—The Ularitide Global Evaluation in Acute Decompensated Heart Failure (URGENT) study. In: European Society of Cardiology; 2008; Milan.
25. P.S. Jhund J.J. McMurray A.P. Davie The acute vascular effects of frusemide in heart failure Br J Clin Pharmacol 50 2000 9 13
26. S.S. Gottlieb D.C. Brater I. Thomas BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy Circulation 105 2002 1348 1353
27. M.S. Weinfeld G.M. Chertow L.W. Stevenson Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure Am Heart J 138 1999 285 290
28. H.A. Cooper D.L. Dries C.E. Davis Y.L. Shen M.J. Domanski Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction Circulation 100 1999 1311 1315
29. V. Hasselblad W. Gattis Stough M.R. Shah Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial Eur J Heart Fail 9 2007 1064 1069
30. G. Cotter E. Metzkor E. Kaluski Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema Lancet 351 1998 389 393
31. K. Damman G. Navis A.A. Voors Worsening renal function and prognosis in heart failure: systematic review and meta-analysis J Card Fail 13 2007 599 608
32. H.M. Krumholz Y.T. Chen V. Vaccarino Correlates and impact on outcomes of worsening renal function in patients > or = 65 years of age with heart failure Am J Cardiol 85 2000 1110 1113
33. G.L. Smith V. Vaccarino M. Kosiborod Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure? J Card Fail 9 2003 13 25
34. P. Levy S. Compton R. Welch Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin: a feasibility and outcome analysis Ann Emerg Med 50 2007 144 152
35. W. Peacock G.C. Fonarow C.L. Emerman R.M. Mills J. Wynne Impact of early initiation of intravenous therapy for acute decompensated heart failure on outcomes in ADHERE Cardiology 107 2006 44 51
36. S.P. Collins L.M. Mielniczuk H.A. Whittingham M.E. Boseley D.R. Schramm A.B. Storrow The use of noninvasive ventilation in emergency department patients with acute cardiogenic pulmonary edema: a systematic review Ann Emerg Med 48 2006 260 269 9 e1–4
37. J. Masip M. Roque B. Sanchez R. Fernandez M. Subirana J.A. Exposito Noninvasive ventilation in acute cardiogenic pulmonary edema: systematic review and meta-analysis JAMA 294 2005 3124 3130
38. M.A. Konstam M. Gheorghiade J.C. Burnett Jr. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial JAMA 297 2007 1319 1331
39. M. Gheorghiade J.S. Rossi W. Cotts Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial Arch Intern Med 167 2007 1998 2005
40. C. Lucas W. Johnson M.A. Hamilton Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure Am Heart J 140 2000 840 847
41. M.R. Cowie M. Komajda T. Murray-Thomas J. Underwood B. Ticho Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH) Eur Heart J 27 2006 1216 1222
42. J.M. Vinson M.W. Rich J.C. Sperry A.S. Shah T. McNamara Early readmission of elderly patients with congestive heart failure J Am Geriatr Soc 38 1990 1290 1295
43. H.M. Krumholz J. Amatruda G.L. Smith Randomized trial of an education and support intervention to prevent readmission of patients with heart failure J Am Coll Cardiol 39 2002 83 89
44. M.W. Rich V. Beckham C. Wittenberg C.L. Leven K.E. Freedland R.M. Carney A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure N Engl J Med 333 1995 1190 1195
45. A.S. Maisel P. Krishnaswamy R.M. Nowak Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167
46. A. Harrison L.K. Morrison P. Krishnaswamy B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea Ann Emerg Med 39 2002 131 138
47. A. Maisel J.E. Hollander D. Guss Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath J Am Coll Cardiol 44 2004 1328 1333
48. J.L. Januzzi R. van Kimmenade J. Lainchbury NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study Eur Heart J 27 2006 330 337
49. C. Mueller K. Laule-Kilian C. Schindler Cost-effectiveness of B-type natriuretic peptide testing in patients with acute dyspnea Arch Intern Med 166 2006 1081 1087
50. A.J. Burger D.P. Horton T. LeJemtel Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study Am Heart J 144 2002 1102 1108
51. W.S. Colucci U. Elkayam D.P. Horton Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group N Engl J Med 343 2000 246 253
52. C.W. Yancy M. Lopatin L.W. Stevenson T. De Marco G.C. Fonarow Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database J Am Coll Cardiol 47 2006 76 84
53. J.D. Sackner-Bernstein M. Kowalski M. Fox K. Aaronson Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials JAMA 293 2005 1900 1905
54. J.D. Sackner-Bernstein H.A. Skopicki K.D. Aaronson Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure Circulation 111 2005 1487 1491
55. S.P. Collins W.R. Hinckley A.B. Storrow Critical review and recommendations for nesiritide use in the emergency department J Emerg Med 29 2005 317 329
56. S.M. Silvers J.M. Howell J.M. Kosowsky I.C. Rokos A.S. Jagoda Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with acute heart failure syndromes Ann Emerg Med 49 2007 627 669
57. W.Ft. Peacock R. Holland R. Gyarmathy Observation unit treatment of heart failure with nesiritide: results from the proaction trial J Emerg Med 29 2005 243 252
58. W.Ft. Peacock J. Young S. Collins D. Diercks C. Emerman Heart failure observation units: optimizing care Ann Emerg Med 47 2006 22 33
59. A.B. Storrow S.P. Collins M.S. Lyons L.E. Wagoner W.B. Gibler C.J. Lindsell Emergency department observation of heart failure: preliminary analysis of safety and cost Congest Heart Fail 11 2005 68 72
60. C.W. Hamm B.U. Goldmann C. Heeschen G. Kreymann J. Berger T. Meinertz Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I N Engl J Med 337 1997 1648 1653
61. F. Kim M. Olsufka W.T. Longstreth Jr. Pilot randomized clinical trial of prehospital induction of mild hypothermia in out-of-hospital cardiac arrest patients with a rapid infusion of 4 degrees C normal saline Circulation 115 2007 3064 3070
62. E. Rivers B. Nguyen S. Havstad Early goal-directed therapy in the treatment of severe sepsis and septic shock N Engl J Med 345 2001 1368 1377
63. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group N Engl J Med 333 1995 1581 1587
64. D.A. Morrow E.M. Antman A. Sayah Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction: results of The Early Retavase-Thrombolysis in Myocardial Infarction (ER-TIMI) 19 trial J Am Coll Cardiol 40 2002 71 77
65. C.T. Hourigan D. Mountain P.E. Langton Changing the site of delivery of thrombolytic treatment for acute myocardial infarction from the coronary care unit to the emergency department greatly reduces door to needle time Heart (British Cardiac Society) 84 2000 157 163
66. A.R. Corfield C.A. Graham J.N. Adams I. Booth A.C. McGuffie Emergency department thrombolysis improves door to needle times Emerg Med J 21 2004 676 680
67. R.H. Mehta L.K. Newby Y. Patel The impact of emergency department structure and care processes in delivering care for non-ST-segment elevation acute coronary syndromes Am Heart J 152 2006 648 660
68. Collins Sp PW, Kontos M, Diercks D, Hiestand B, Hogan C, Mueller C, et al. Heart Failure and Audicor Technology for Rapid Diagnosis and Initial Treatment of ED Patients with Suspected Heart Failure (HEARD-IT). In: Society of Academic Emergency Medicine; 2007; Chicago.
69. J.E. Hollander The management of cocaine-associated myocardial ischemia N Engl J Med 333 1995 1267 1272
70. A.B. Storrow S. Collins T. Disalvo J. Han Improving Heart Failure Risk Stratification in the ED Stratify 1R01HL088459-01 2007 Vanderbilt University: NHLBI
71. A.B. Storrow W.B. Gibler Chest pain centers: diagnosis of acute coronary syndromes Ann Emerg Med 35 2000 449 461
72. M.T. Roe R.H. Christenson E.M. Ohman A randomized, placebo-controlled trial of early eptifibatide for non-ST-segment elevation acute coronary syndromes Am Heart J 146 2003 993 998
73. P.S. Pang J.G. Cleland J.R. Teerlink A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach Eur Heart J 29 2008 816 824
74. J.J. McMurray J.R. Teerlink G. Cotter Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials JAMA 298 2007 2009 2019
75. G.C. Fonarow J.T. Heywood P.A. Heidenreich M. Lopatin C.W. Yancy Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE) Am Heart J 153 2007 1021 1028
76. G.C. Fonarow W.G. Stough W.T. Abraham Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry J Am Coll Cardiol 50 2007 768 777